Helex Secures $3.5M Seed Funding for Kidney-Targeted Gene Therapy
Delivering therapeutic cargo to kidney cells has long been considered one of the most difficult challenges in drug delivery. Helex recently announced an oversubscribed $3.5 million seed round to advance its non-viral gene therapy approach for genetic kidney diseases, bringing […]
Helex Secures $3.5M Seed Funding for Kidney-Targeted Gene Therapy Read More »










